Vnitr Lek 2013, 59(12):1037-1038

Indikátory zánětu u pacientů s koronární aterosklerózou - editorial

F. Málek
Kardiovaskulární centrum Nemocnice Na Homolce Praha, přednosta prim. MUDr. Ivo Skalský, MBA

Received: April 20, 2013; Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Málek F. Indikátory zánětu u pacientů s koronární aterosklerózou - editorial. Vnitr Lek. 2013;59(12):1037-1038.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481-2485. Go to original source... Go to PubMed...
    2. Oą»ádal P. C-reaktivní protein - molekula, která změnila kardiologii. Editorial k článku Dvořáková A et al. Ultrasenzitivně měřený - C-reaktivní protein - nový parametr kardiovaskulárního rizika. Vnitř Lék 2004; 50: 852-857. Go to PubMed...
    3. Mora S, Ridker PM. Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) - Can C-Reactive Protein Be Used to Target Statin Therapy in Primary Prevention? Am J Cardiol 2006; 97: 33A-41A. Go to original source... Go to PubMed...
    4. Rocker PM. JUPITER Study Group. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Engl J Med 2008; 359: 2195-2207. Go to original source... Go to PubMed...
    5. Betteridge DJ, Gibson JM, Sager PT. Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (< 2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study). Am J Cardiol 2007; 100: 1245-1248. Go to original source... Go to PubMed...
    6. Kjekshus J, Apetrei E, Barrios V et al. CORONA Group. Rosuvastatin in Older Patients with Systolic Heart Failure. N Engl J Med 2007; 357: 2248-2261. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.